Table 1.
Experimental groups.
| Groups | Induction of SCI | Treatment |
|---|---|---|
| HA_PM_iNPC (non-injured) | No | Hyaluronic acid scaffold with PM-embedded iNPCs |
| HA_PPY_PM_iNPC (non-injured) | No | Hyaluronic acid scaffold with PPY fibers and PM-embedded iNPCs |
| HA_PM_CURC | Yes | Hyaluronic acid scaffold and PM-embedded CURC |
| HA_PPY_PM_CURC | Yes | Hyaluronic acid scaffold with PPY fibers and PM-embedded CURC |
| HA_PM_iNPC | Yes | Hyaluronic acid scaffold with PM-embedded iNPCs |
| HA_PPY_PM_iNPC | Yes | Hyaluronic acid scaffold with PPY fibers and PM-embedded iNPCs |
| HA_PM_CURC_iNPC | Yes | Hyaluronic acid scaffold with PM-embedded iNPCs and CURC |
| HA_PPY_PM_CURC_iNPC | Yes | Hyaluronic acid scaffold with PPY fibers, PM-embedded iNPCs, and CURC |
Abbreviations—HA: hyaluronic acid; PM: PuraMatrix; PPY: polypyrrole fibers; iNPCs: human-induced neural progenitor cells; CURC: nanoconjugated curcumin.